Boiron SA (BOIRF)

Market Cap	430.41M
Revenue (ttm)	504.77M
Net Income (ttm)	11.74M
Shares Out	n/a
EPS (ttm)	0.68
PE Ratio	36.67
Forward PE	13.51
Dividend	n/a
Ex-Dividend Date	n/a

Volume	250
Average Volume	325
Open	24.00
Previous Close	n/a
Day's Range	24.00 - 24.00
52-Week Range	24.00 - 35.85
Beta	0.46
RSI	34.05
Earnings Date	Sep 5, 2025

About Boiron

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products include medical devices, invitro diagnostics, dietary supplements, cosmetics, and phytotherapy. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatme...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1932
• Employees: 2,771
• Stock Exchange: OTCMKTS
• Ticker Symbol: BOIRF

Financial Performance

In 2024, Boiron's revenue was 487.56 million, a decrease of -1.15% compared to the previous year's 493.25 million. Earnings were 11.34 million, a decrease of -68.36%.

Financial numbers in EUR